A systematic review and meta-regression analysis on the impact of increasing IgG trough level on infection rates in primary immunodeficiency patients on intravenous …
JL Lee, N Mohamed Shah, M Makmor-Bakry… - Journal of clinical …, 2020 - Springer
Journal of clinical immunology, 2020•Springer
Purpose We conducted a systematic review and meta-regression analysis to evaluate the
impact of increasing immunoglobulin G (IgG) trough levels on the clinical outcomes in
patients with PID receiving intravenous immunoglobulin G (IVIG) treatment. Methods
Systematic search was conducted in PubMed and Cochrane. Other relevant articles were
searched by reviewing the references of the reviewed article. All clinical trials with
documented IgG trough levels and clinical outcome of interest in patients receiving IVIG …
impact of increasing immunoglobulin G (IgG) trough levels on the clinical outcomes in
patients with PID receiving intravenous immunoglobulin G (IVIG) treatment. Methods
Systematic search was conducted in PubMed and Cochrane. Other relevant articles were
searched by reviewing the references of the reviewed article. All clinical trials with
documented IgG trough levels and clinical outcome of interest in patients receiving IVIG …
Purpose
We conducted a systematic review and meta-regression analysis to evaluate the impact of increasing immunoglobulin G (IgG) trough levels on the clinical outcomes in patients with PID receiving intravenous immunoglobulin G (IVIG) treatment.
Methods
Systematic search was conducted in PubMed and Cochrane. Other relevant articles were searched by reviewing the references of the reviewed article. All clinical trials with documented IgG trough levels and clinical outcome of interest in patients receiving IVIG treatment were eligible to be included in this review. Meta-regression analysis was conducted using Comprehensive Meta-analysis Software. Additional sensitivity analyses were undertaken to evaluate the robustness of the overall results.
Results
Twenty-eight clinical studies with 1218 patients reported from year 2001 to 2018 were included. The mean IVIG dose used ranges from 387 to 560 mg/kg every 3 to 4 weekly, and mean IgG trough obtained ranges from 660 to 1280 mg/dL. Random-effects meta-regression slope shows that IgG trough level increases significantly by 73 mg/dL with every increase of 100 mg/kg dose of IVIG (p < 0.05). Overall infection rates reduced significantly by 13% with every increment of 100 mg/dL of IgG trough up to 960 mg/dL (p < 0.05).
Conclusion
This meta-analysis concludes that titrating the IgG trough levels up to 960 mg/dL progressively reduces the rate of infections, and there is less additional benefit beyond that. Further studies to validate this result are required before it can be used in clinical practice.
Springer
